Edward Murphy, MD, MPH

Displaying 151 - 169 of 169

  1. Custer B, Johnson ES, Sullivan SD, Hazlet TK, Ramsey SD, Murphy EL, Busch MP. Community blood supply model: development of a new model to assess the safety, sufficiency, and cost of the blood supply. Med Decis Making. 2005 Sep-Oct; 25(5):571-82.
    http://www.ncbi.nlm.nih.gov/pubmed/16160212
  2. Roucoux DF, Wang B, Smith D, Nass CC, Smith J, Hutching ST, Newman B, Lee TH, Chafets DM, Murphy EL. A prospective study of sexual transmission of human T lymphotropic virus (HTLV)-I and HTLV-II. J Infect Dis. 2005 May 01; 191(9):1490-7.
    http://www.ncbi.nlm.nih.gov/pubmed/15809908
  3. Murphy E, Jacobson S, Franchini G, Taylor GP, Hanchard B, Morgan O, Lairmore M. International Retrovirology Association brings together scientists and clinicians to bridge discoveries about human T-lymphotropic viruses from the laboratory to clinical trials. Retrovirology. 2005 Mar 29; 2:22.
    http://www.ncbi.nlm.nih.gov/pubmed/15796774
  4. Jarvis GA, Janoff EN, Cheng H, Devita D, Fasching C, McCulloch CE, Murphy EL. Human T lymphotropic virus type II infection and humoral responses to pneumococcal polysaccharide and tetanus toxoid vaccines. J Infect Dis. 2005 Apr 15; 191(8):1239-44.
    http://www.ncbi.nlm.nih.gov/pubmed/15776369
  5. Sanchez AM, Schreiber GB, Nass CC, Glynn S, Kessler D, Hirschler N, Fridey J, Bethel J, Murphy E, Busch MP. The impact of male-to-male sexual experience on risk profiles of blood donors. Transfusion. 2005 Mar; 45(3):404-13.
    http://www.ncbi.nlm.nih.gov/pubmed/15752159
  6. Lee TH, Chafets DM, Busch MP, Murphy EL. Quantitation of HTLV-I and II proviral load using real-time quantitative PCR with SYBR Green chemistry. J Clin Virol. 2004 Dec; 31(4):275-82.
    http://www.ncbi.nlm.nih.gov/pubmed/15494269
  7. Custer B, Tomasulo PA, Murphy EL, Caglioti S, Harpool D, McEvoy P, Busch MP. Triggers for switching from minipool testing by nucleic acid technology to individual-donation nucleic acid testing for West Nile virus: analysis of 2003 data to inform 2004 decision making. Transfusion. 2004 Nov; 44(11):1547-54.
    http://www.ncbi.nlm.nih.gov/pubmed/15504158
  8. Custer B, Johnson ES, Sullivan SD, Hazlet TK, Ramsey SD, Hirschler NV, Murphy EL, Busch MP. Quantifying losses to the donated blood supply due to donor deferral and miscollection. Transfusion. 2004 Oct; 44(10):1417-26.
    http://www.ncbi.nlm.nih.gov/pubmed/15383013
  9. Murphy EL, Lee TH, Chafets D, Nass CC, Wang B, Loughlin K, Smith D. Higher human T lymphotropic virus (HTLV) provirus load is associated with HTLV-I versus HTLV-II, with HTLV-II subtype A versus B, and with male sex and a history of blood transfusion. J Infect Dis. 2004 Aug 01; 190(3):504-10.
    http://www.ncbi.nlm.nih.gov/pubmed/15243924
  10. Roucoux DF, Murphy EL. The epidemiology and disease outcomes of human T-lymphotropic virus type II. AIDS Rev. 2004 Jul-Sep; 6(3):144-54.
    http://www.ncbi.nlm.nih.gov/pubmed/15595431
  11. Murphy EL, David Connor J, McEvoy P, Hirschler N, Busch MP, Roberts P, Nguyen KA, Reich P. Estimating blood donor loss due to the variant CJD travel deferral. Transfusion. 2004 May; 44(5):645-50.
    http://www.ncbi.nlm.nih.gov/pubmed/15104643
  12. Orland JR, Wang B, Wright DJ, Nass CC, Garratty G, Smith JW, Newman B, Smith DM, Murphy EL. Increased mortality associated with HTLV-II infection in blood donors: a prospective cohort study. Retrovirology. 2004 Mar 24; 1:4.
    http://www.ncbi.nlm.nih.gov/pubmed/15169553
  13. Murphy EL, Wang B, Sacher RA, Fridey J, Smith JW, Nass CC, Newman B, Ownby HE, Garratty G, Hutching ST, Schreiber GB. Respiratory and urinary tract infections, arthritis, and asthma associated with HTLV-I and HTLV-II infection. Emerg Infect Dis. 2004 Jan; 10(1):109-16.
    http://www.ncbi.nlm.nih.gov/pubmed/15078605
  14. Murphy EL, Grant RM, Kropp J, Oliveira A, Lee TH, Busch MP. Increased human T-lymphotropic virus type II proviral load following highly active retroviral therapy in HIV-coinfected patients. J Acquir Immune Defic Syndr. 2003 Aug 15; 33(5):655-6.
    http://www.ncbi.nlm.nih.gov/pubmed/12902815
  15. Murphy EL, Ownby HE, Smith JW, Garratty G, Hutching ST, Wu Y, Ameti DI. Pulmonary function testing in HTLV-I and HTLV-II infected humans: a cohort study. BMC Pulm Med. 2003 Jul 28; 3:1.
    http://www.ncbi.nlm.nih.gov/pubmed/12885299
  16. Glynn SA, Busch MP, Schreiber GB, Murphy EL, Wright DJ, Tu Y, Kleinman SH. Effect of a national disaster on blood supply and safety: the September 11 experience. JAMA. 2003 May 07; 289(17):2246-53.
    http://www.ncbi.nlm.nih.gov/pubmed/12734136
  17. Asmuth DM, Kalish LA, Laycock ME, Murphy EL, Mohr BA, Lee TH, Gallarda J, Giachetti C, Dollard SC, van der Horst CM, Grant RM, Busch MP. Absence of HBV and HCV, HTLV-I and -II, and human herpes virus-8 activation after allogeneic RBC transfusion in patients with advanced HIV-1 infection. Transfusion. 2003 Apr; 43(4):451-8.
    http://www.ncbi.nlm.nih.gov/pubmed/12662277
  18. Schreiber GB, Glynn SA, Damesyn MA, Wright DJ, Tu Y, Dodd RY, Murphy EL. Lapsed donors: an untapped resource. Transfusion. 2003 Jan; 43(1):17-24.
    http://www.ncbi.nlm.nih.gov/pubmed/12519426
  19. Murphy EL, De Ceulaer K, Williams W, Clark JW, Saxinger C, Gibbs WN, Blattner WA. Lack of relation between human T-lymphotropic virus type I infection and systemic lupus erythematosus in Jamaica, West Indies. J Acquir Immune Defic Syndr. 1988; 1(1):18-22.
    http://www.ncbi.nlm.nih.gov/pubmed/3216294